Drug Profile
GSK 705498
Alternative Names: 705498; GSK-705498; SB-705498Latest Information Update: 01 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Bromobenzenes; Non-opioid analgesics; Pyridines; Pyrrolidines; Small molecules
- Mechanism of Action TRPV1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic rhinitis; Atopic dermatitis; Cough; Dental pain; Migraine; Pain; Pruritus; Rhinitis
Most Recent Events
- 31 Jul 2012 Phase-I clinical trials in Atopic dermatitis in United Kingdom (Topical)
- 26 Jan 2012 GlaxoSmithKline completes a phase II trial in Cough in United Kingdom (NCT01476098)
- 28 Sep 2011 Efficacy data from clinical trials in Rhinitis presented at the 21st Annual Congress of the European Respiratory Society (ERS-2011)